Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
Feb 24, 2024
0
1
A team of University of Maryland researchers has made new strides in the fight against metastatic cancer by successfully combining three cutting-edge photoimmunotherapy technologies to help prevent the spread and return of ...
Oct 25, 2023
0
4
For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...
Aug 22, 2014
0
0
Duke researchers made a big splash in the news last spring when 60 Minutes featured the success of early clinical trials using a modified poliovirus in the fight against a deadly form of brain cancer. Now, with funding from ...
Aug 27, 2015
0
47
A non-toxic, bacteria-based system developed at the University of Massachusetts Amherst can detect when it is inside a cancer cell and then release its payload of therapeutic drugs directly into the cell. The work, published ...
Oct 21, 2021
0
102
Cancer researchers have applied a comprehensive set of analytical tools to lethal cases of metastatic prostate cancer, yielding a detailed map of the complex networks of interactions among genes and proteins that enable prostate ...
Aug 4, 2016
0
3
Patients with metastatic breast cancer carrying a particular mutation fare better on one form of hormone therapy than another and can be identified using a blood test, according to a new study.
Oct 8, 2020
0
12
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St. Michael's ...
Mar 25, 2020
0
100
NewYork-Presbyterian and Weill Cornell Medicine have begun the first clinical trial in the United States that uses a small molecule to treat men with progressive prostate cancer that has spread beyond the prostate and is ...
May 31, 2017
0
2
In a small, phase I clinical trial, Johns Hopkins Kimmel Cancer Center researchers say they show for the first time that the experimental drug guadecitabine (SGI-110) is safe in combination with the chemotherapy drug irinotecan ...
Apr 15, 2016
0
129
